Convergence Investment Partners, LLC Ani Pharmaceuticals Inc Transaction History

Convergence Investment Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 22, 2020	SELL	$55.65 - $79.83 $107,682 - $154,471	-1,935 Closed	0 $0
Q3 2019 Oct 22, 2019	SELL	$64.7 - $85.39 $4,205 - $5,550	-65 Reduced 3.25%	1,935 $141,000
Q2 2019 Jul 23, 2019	BUY	$67.77 - $82.2 $135,540 - $164,400	2,000 New	2,000 $164,000

211

18.7M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $930M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Convergence Investment Partners, LLC with notifications on news.